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Abstract: Macrophages are present in all tissues, either as resident 
cells or monocyte-derived cells that infiltrate into tissues.  The tissue 
site largely determines the phenotype of tissue-resident cells, which 
help to maintain tissue homeostasis and act as sentinels of injury. Both 
tissue resident and recruited macrophages make a substantial contribution 
to wound healing following injury. In this review, we evaluate how 
macrophages in two fundamentally distinct tissues, i.e. the lung and the 
skin, differentially contribute to the process of wound healing. We 
highlight the commonalities of macrophage functions during repair and 
contrast them with distinct, tissue-specific functions that macrophages 
fulfill during the different stages of wound healing. 
 
 
 
 
Minor suggested changes/corrections/typos: 
 
1. Introduction, paragraph 1: In the sentence referring to Figure 1, perhaps a 
minor modification can be made to highlight that Figure 1 specifically depicts the 
various phases of wound healing in the skin. For example, "……..and during "tissue 
remodelling" wound re-organization restructures the tissue [2], as is shown for 
the skin in Figure 1." 
 
Change made as suggested. Highlighted in yellow 
 
2. In the section "Architecture and function of the skin", paragraph 1: should the 
authors indicate that there are three layers of skin, rather than two (i.e. include 
hypodermis/subcutaneous layer)? This also applies to the figure legend for Fig 2. 
 
Most literature still considers the skin to have only two layers, but we have now specifically added 
reference to the subcutaneous tissue lying beneath the dermis. Highlighted in yellow 
 
3. In the section "Tissue resident macrophage populations during the immediate 
responses to wounding", paragraph 2: the sentence "As a consequence, release of 
intracellular ATP can promote macrophage proliferation and enhance wound repair 
[27]" seems a little out of place here. The cited study showed the therapeutic 
effects of administration of ATP-encapsulated in lipid vesicles. Whilst the study is 
relevant to this review and could be included and discussed, this would not seem 
to be relevant to the biology of ATP release from cells, as pertains to this 
paragraph. In fact, ATP, released as a DAMP, can trigger macrophage cell death 
via P2X7. Perhaps the authors could alter this paragraph slightly, by elaborating 
on biological roles of P2Y vs P2X receptors, and moving the sentence in question 
elsewhere (or providing a clearer flow of logic in relation to the rest of this 
paragraph or removing altogether). 
 
We have reworked this section. Highlighted in yellow 
 
4. In the section "The inflammatory response and influx of monocyte 
populations": although this section focuses on monocyte recruitment, there is also 
some discussion of neutrophil recruitment. The authors might like to consider 
describing the essential role of perivascular macrophages in the initial wave of 
neutrophil recruitment to the skin, since this has been very elegantly 
demonstrated in a bacterial infection model: Abtin et al, Nature Immunol, 2014, 
PMID: 24270515.  
 
We have now mentioned this study. Highlighted in yellow 
 
All the minor corrections requested have been made.  
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Abstract: 
Macrophages are present in all tissues, either as resident cells or monocyte-derived 
cells that infiltrate into tissues.  The tissue site largely determines the phenotype of 
tissue-resident cells, which help to maintain tissue homeostasis and act as sentinels of 
injury. Both tissue resident and recruited macrophages make a substantial contribution 
to wound healing following injury. In this review, we evaluate how macrophages in 
two fundamentally distinct tissues, i.e. the lung and the skin, differentially contribute 
to the process of wound healing. We highlight the commonalities of macrophage 
functions during repair and contrast them with distinct, tissue-specific functions that 
macrophages fulfill during the different stages of wound healing.  
 
Keywords: 
Macrophage, Tissue Repair, Extra-cellular matrix, inflammation, lung, skin 
 
Introduction 
Wound healing is a highly dynamic and tightly coordinated process to achieve 
restoration of tissue integrity after infection or physical trauma. Fundamentally, this 
process can be divided into three overlapping but distinct phases. These phases have 
been defined as “coagulation and inflammation”, “tissue formation” and “tissue 
remodeling” [1]. During “coagulation and inflammation” the wound is provisionally 
closed by a blood clot and recruitment of inflammatory cells is initiated; during 
“tissue formation” pro-inflammatory signals decline and cell proliferation is initiated 
by local growth factors; and during “tissue remodeling” wound re-organization 
restructures the tissue [2] as shown for the skin in Figure 1. Cells from the 
monocyte/macrophage lineage are critical players following tissue damage, and 
depletion of macrophages results in impaired wound healing [3-5]. In particular the 
capacity of myeloid cells to regulate inflammation, to remove apoptotic cell debris 
and to promote cell proliferation have supported the notion that macrophages 
critically orchestrate the repair and healing response of damaged tissues [6]. 
Macrophages are present during all stages of the repair process and conditional 
depletion during the different phases of wound healing has revealed that macrophages 
fulfill distinct functional roles at the different stages, and emphasizes the great 
diversity and plasticity macrophages display during this process [7]. 
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While many processes during wound repair are evolutionary conserved and follow 
similar mechanisms in different organisms and individual tissues, many other aspects 
of wound repair are regulated in a tissue specific context. Accordingly, tissue resident 
macrophage populations differ substantially from each other and may contribute to 
local wound healing in a tissue specific fashion. In this review, we compare the 
contribution of different macrophage populations to wound healing in two 
fundamentally distinct tissues, the skin and the lung. In this way, we separate 
common macrophage functions in wound healing from tissue-specific functions of 
macrophages, and review their distinct roles during the different phases of wound 
healing. Based on these different aspects, we propose a common model for the 
function of macrophages during wound healing.  
 
Architecture and function of the skin  
The skin forms a physical barrier between the organism and its environment, and thus 
a pivotal function of the skin is the protection from chemical and physical assaults, as 
well as from pathogen invasion and to prevent unregulated water loss [8]. Mammalian 
skin is composed of mainly two layers, the epidermis and the dermis, with a fat-rich 
subcutaneous tissue lying beneath the dermis (Figure 2a). The epidermal layer is rich 
in cells and comprises a physical, chemical and immunological barrier, and the 
dermis, which is rich in extracellular matrix that provides tensile strength and 
elasticity. The epidermis is a squamous epithelium composed of different layers, 
supported by self-renewing proliferating tissue-stem cells within the basal layer [9]. 
The dermis is tightly connected to the epidermis by the basement membrane and 
consists of different cell types, including fibroblasts and endothelial cells. 
Appendages such as hair roots, sebaceous glands and sweat glands are located in the 
dermal part.   
 
Two types of macrophage populations reside in the skin: Langerhans cells (LCs) 
which are mainly located in the epidermal layer, and dermal macrophages, which are 
the dominant macrophage population in the dermis. LCs originate from yolk-sac 
derived progenitors and fetal liver monocytes, which are recruited to the epidermis 
before birth [10]. Under steady state conditions, LCs self-renew and only upon 
inflammation do blood monocytes replenish the epidermal LC population [11, 12]. 
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LCs are defined by their expression of the lectin receptor langerin (CD207). In 
addition, LCs express CD11c and CD11b and are positive for F4/80 and MHCII. In 
contrast, dermal macrophages express F4/80 and CD11b but no CD11c or Langerin 
and only low levels of MHCII [13]. While the contribution of macrophages during 
wound healing is well established, the specific repair function of LCs is yet to be 
determined [14].  It is known that LCs re-populate the epidermis in the process of 
wound closure and increased numbers have been correlated with healing in diabetic 
foot ulcer patients [15] suggesting LCs are beneficial. 
 
Pulmonary environment and lung macrophages 
The main function of the lung is to allow for oxygen uptake (Figure 2b). To achieve 
this function the human lung has an enormous exposed area - approximately the size 
of a tennis court [16]. This exposure carries the risk that the lung will initiate 
inflammation upon inhaled bacteria, viruses, oxidants, pollutants and allergens, 
compromising tissue integrity. However, a protective barrier of innate immune 
components functions to maintain a tolerant state towards innocuous antigens present 
in the inhaled air. This barrier is made up of mucus and the alveolar fluid, which is 
rich in pulmonary surfactants and opsonins including immunoglobulins, complement 
and collectins (Surfactant proteins A and D) [16]. Additionally, different types of 
macrophages (bronchial macrophages, interstitial macrophages and alveolar 
macrophages) reside in distinct spaces within the lungs [17]. Alveolar macrophages 
are embedded in the alveolar fluid, covering the alveolar surface (Figure 2b) and are 
defined in the mouse by their high expression of the sialic acid-binding 
immunoglobulin-type lectin F (Siglec F) and the alpha integrin CD11c. In addition, 
alveolar macrophages express typical macrophage markers such as CD11b, F4/80, 
MerTK and CD64. In contrast, interstitial macrophages, which are the dominant 
macrophage population in the lung interstitium, express F4/80, CD11b and MHCII, 
but express low levels of CD11c [17]. Under steady state conditions, alveolar 
macrophages comprise 90-95% of the cells in the alveolar space and similar to LCs 
are foetal liver monocyte-derived and self-renewing [18, 19]. Alveolar macrophages 
are required for surfactant catabolism and maintaining lung homeostasis [20]. In 
addition, alveolar macrophages remove antigenic particles and through a variety of 
mechanisms actively down-regulate inflammation and promote a state of immune 
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tolerance [16, 21]. In contrast to alveolar macrophages, interstitial macrophages are 
located within the lung tissue and are not in direct contact with the alveolar fluid and 
the exterior environment. Although the interstitial macrophages are a cell population 
that remains largely uncharacterized, it has been suggested that they can join alveolar 
macrophages in their role of dampening inflammation [22].  
 
Tissue resident macrophage populations during the immediate responses to 
wounding 
A number of evolutionary conserved reactions lead to a rapid activation of tissue 
resident macrophages and initiate an inflammatory response upon wounding (Figure 
1). This first response to tissue injury involves a rapid release of calcium by damaged 
cells that travels as a wave via through adjacent cells to activate NADPH oxidase 
[23]. The NADPH oxidase mediates the production of hydrogen peroxide H2O2, 
known to be an immediate damage signal [24]. Calcium and hydrogen peroxide are 
thus the earliest known signals after tissue damage that mobilize epithelial cells and 
bring immune cells to the site of wounding [24, 25]. In monocytes/macrophages H2O2 
has been shown to trigger the active release of high-mobility group box 1 protein 
(HMGB-1) [26]. HMGB-1 release is a potent mediator of systemic inflammation, 
when passively released by necrotic cells, and is reported to be one of the first 
amplifiers of the pro-inflammatory cascade upon wounding [26].  
 
Other factors that lead to immediate activation of tissue resident macrophages are 
cell-endogenous molecules that are constitutively expressed and released upon tissue 
damage. These ‘danger-associated molecular patterns’ (DAMPs) can for instance be 
molecules such as HMGB-1 or ATP. ATP in blood normally has a half-life of less 
than 40 seconds. However, intracellular ATP released by wounding can be rapidly 
recognized by two different classes of purigenic receptors, P2Y (a G-protein coupled 
receptor) and P2X (a ligand-gated ion channel), which are both expressed on a 
number of tissue resident macrophages. Although P2YR signaling may contribute to 
repair through the uptake of apoptotic cells, both P2YR and particularly P2XR have 
strong pro-inflammatory effects, promoting recruitment of inflammatory cells to the 
site of injury[27]. In addition, a number of cytokines are pre-stored in tissue cells, 
which are then rapidly processed and released upon injury. These ‘alarmins’ including 
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IL-1α and IL-33, target tissue resident macrophages, such as alveolar macrophages, 
and induce their activation [28]. 
 
In parallel, damage of blood vessels causes blood leakage that then rapidly activates a 
coagulation cascade resulting in the formation of a clot (Figure 1). This clot serves as 
a first protective shield against invading pathogens and ongoing blood loss. It consists 
of platelets that are embedded in cross-linked fibrin fibers derived by thrombin 
cleavage of fibrinogen [1]. In the lung, coagulation occurs not only intra-vascularly in 
a milieu containing the complete plasma clotting system, but also extra-vascularly 
within the alveolar cavities [29]. Alveolar macrophages directly contribute to this pro-
coagulant activity [30], potentially via the production of tissue factor and thereby help 
initiate the coagulation cascade [31]. Beyond the essential function of preventing 
blood loss, coagulation also contributes directly to the subsequent inflammatory and 
fibro-proliferative responses during wound healing via activation of resident 
macrophages [32]. For example, clot formation in itself releases substantial amounts 
of free heme, a DAMP that causes oxidative damage and acts on macrophages to 
promote a pro-inflammatory cascade [33].  
 
All these different pathways induce an immediate pro-inflammatory environment 
around the wound, which within hours after injury leads to the rapid influx of 
additional leukocyte populations, such as neutrophils and monocytes [34]. Since this 
immediate response to injury is so highly conserved in all tissues, macrophages in 
both the skin and the lungs act as sentinels of tissue homeostasis and both have the 
capability to recognize immediate danger signals and to initiate the inflammatory 
phase of wound healing.  
 
The inflammatory response and influx of monocyte populations 
The induction of a pro-inflammatory environment within the ruptured tissue leads to 
the influx of neutrophils and monocytes (Figure 3a). In response to tissue-specific 
signals these monocytes then differentiate into macrophages and join tissue resident 
macrophage populations in driving the restoration of tissue integrity. The 
differentiation of monocyte populations during wound healing has been studied 
particularly well in skin injury models, using reporter mouse strains and in vivo 
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imaging. It has been shown that by the induction of chemokines, activated 
perivascular macrophages are major players in the process of neutrophil recruitment 
to inflamed skin [35]. Furthermore, it had been assumed that within the first hours 
after damage it was exclusively neutrophils that infiltrate the damage site, followed by 
monocytes as early as 24 to 48 hrs post injury [36]. However, recent imaging data by 
Rodero and colleagues revealed that an initial wave of monocytes enters the wound at 
the same time as neutrophils are accumulating and that monocytes infiltrate the 
wound bed through micro-hemorrhages caused by disrupted vessel integrity. These 
monocytes directly crawl trough vascular leakage and spread randomly into the 
wound bed [37].  
 
In the skin, this first sequence of monocyte infiltration is followed by a second phase 
of monocyte infiltration starting 24hrs post wounding, whereby the type of monocytes 
that infiltrate the wound changes over time (Figure 3a). Two fundamentally different 
subsets of monocytes have been identified to infiltrate the wound bed. One monocyte 
population is characterized by the expression of the chemokine receptor CCR-2 
(which are equivalent to CD14 expressing monocytes in humans), and the other is 
characterized by the expression of the chemokine receptor CX3CR-1 (which are 
equivalent to CD16 expressing monocytes in humans) [38-40]. Using CCR-2/GFP 
reporter mice it was shown that CCR-2 expressing monocytes are predominantly 
recruited to skin wounds in the first days following wounding. Accordingly, the 
absolute number of macrophages at the site of wounding is significantly reduced in 
CCR-2 deficient mice during the early phase of wounding [41]. As CCR-2 deficient 
mice had reduced blood vessel formation within the wound bed, this subset of 
monocytes has been assumed to be pro-angiogenic. Other processes of wound 
healing, such as wound closure rate and scar formation, were not altered in CCR-2 
deficient mice [41].  The early influx of monocytes gives rise to macrophage that 
express iNOS, IL-1b and IL-6 [41] (Figure 3a). It is thus assumed that a key function 
of monocyte-derived cells, along with neutrophils during the inflammatory phase is to 
contribute to the defense against microorganisms, which might have entered the 
wound.  
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In contrast to the early influx of CCR-2 expressing monocytes, an influx of CX3CR-1 
expressing monocytes is observed at later stages of skin wound repair (Figure 3a). 
Consistent with the different kinetics of infiltration, in CX3CR-1 deficient mice, 
unlike CCR-2 deficient mice, impaired healing was most pronounced at the late stage 
of repair in models of excisional or burn wounds [42, 43]. These findings strongly 
suggest that the two wound-infiltrating monocyte populations have distinct functions 
during wound repair, with CCR-2 expressing monocytes substantially contribute to 
neo-angiogenesis of the wound bed, while CX3CR-1 expressing monocytes 
contribute more to wound closure and the deposition of extracellular matrix 
component within the wound.  However, in neither CCR-2 nor CX3CR-1 deficient 
mice were wound macrophages completely abrogated suggesting a level of 
redundancy between the populations with both contributing to the wider macrophage 
pool present in the wound bed [42].  
 
Despite their distinct contributions to wound healing, the exact fate of the different 
infiltrating monocyte populations remains poorly understood. In addition, the tissue-
specific mechanisms underlying the transition from an inflammatory monocyte into 
tissue-resident macrophages and the extent to which different infiltrating monocyte 
populations contribute to the macrophage pool remain to be fully understood. 
However, for both locations, in the skin as in the lung, it has become apparent that 
monocyte-derived macrophages in both tissues have specific functions during tissue 
repair, which separate them from tissue-resident macrophages. 
 
Role of macrophages during the tissue formation phase 
The tissue formation phase of wound healing is characterized by dynamic cellular 
proliferation and differentiation of cells along with the creation of new extracellular 
matrix (ECM) and deposition of collagen to support the new cells (Figure 1). The 
process is orchestrated by cell-cell and cell-ECM interactions. Additionally, an 
integral part of this process is that inflammation and new cell recruitment must be 
actively suppressed [44]. Data from excisional punch biopsy of the skin, show that 
macrophages are the dominant immune cells during the tissue formation phase [7]. 
When cells of the myeloid lineage are conditionally depleted at a very early 
inflammatory stage, mice exhibit reduced vascularization of the wound bed and 
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impaired re-epithelialization. However, depletion at the tissue formation stage, when 
several different monocyte population have already infiltrated the wound, has 
devastating effects on the progression of wound healing and leads to massive 
hemorrhage [7].  The critical role of macrophages to efficient wound healing is thus 
particularly apparent during the tissue-formation phase [4, 7] because they contribute 
to all aspects of this highly complex orchestra of cell growth, matrix deposition and 
controlled inflammation.    
 
In both the lung and the skin macrophages are major sources of growth factors [41, 
45-49]. Macrophage-derived growth factors not only induce differentiation and 
proliferation of cells but also induce ECM deposition [50]. Because ECM can bind 
growth factors, it regulates their activity. ECM functions as a reservoir for growth 
factors, concentrates their activity in the vicinity of cells and protects them from 
degradation. A key player in this orchestra is heparan sulfate, which as a component 
of the newly formed ECM underneath the wound, binds and enriches a number of 
different growth factors [50]. Heparan sulfate can potentiate the biological activity of 
VEGF, the basic fibroblast growth factor (FGF-2), the EGF-like growth factor 
Amphiregulin or the transforming growth factor-β (TGF-β). These growth factors 
target structural and progenitor cell populations such endothelial cells, mesothelial 
cells and potentially pericytes [51] to proliferate or survive as well as differentiate 
into one or more cell types contributing to wound repair [50, 52].  
 
One prominent example demonstrating the pivotal role of macrophages during this 
phase of tissue repair is VEGF mediated neo-angiogenis of the wound bed. Wound 
angiogenesis, which is sprouting of capillaries from existing blood vessels into the 
wound bed, are promoted by growth factors such as VEGF-A. Angiogenesis is vital 
for healing and repair, because it supplies the newly formed tissue with nutrients and 
oxygen. The source of VEGF within the wound has been particularly well studied in a 
model of skin repair [41]. Using reporter mice, macrophages were identified as the 
major source of VEGF during an early healing stage – while, at later stages, most 
VEGF expressing cells were found within the neo-epithelium itself [41]. Accordingly, 
mice deficient for VEGF within the myeloid lineage (VEGF
fl/fl
 x LysM-cre) showed 
impaired vascularization in early phases of wound healing. Since vascularization 
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finally recovered in these mice, these data suggest that myeloid-derived VEGF is 
important for the induction of wound angiogenesis, whereas at later stages epidermal 
cells might be able to take over as the critical source of VEGF during skin repair [41].  
 
Resolution of inflammation during the tissue formation phase 
Resolution of inflammation is a necessary step in the process that allows the 
formation and growth of new tissue, and macrophages actively contribute by the 
secretion of macrophage-derived anti-inflammatory cytokines. One of the first steps 
to initiate both resolution of inflammation and the initiation of tissue formation is the 
ingestion of apoptotic neutrophils by macrophages. Mice which are impaired in their 
ability to take up apoptotic neutrophils exhibit delayed healing of excisional skin 
wounds [53]. Phagocytosis of apoptotic cell debris triggers the release of growth 
factors such as vascular endothelial growth factor
 
(VEGF) [54] or hepatocyte growth 
factor (HGF) [55], which are known to be crucial for tissue repair after injury. 
Additionally, it has long been known that ingestion of apoptotic neutrophils 
stimulates the release of anti-inflammatory mediators by macrophages [56], in 
particular TGF-beta, a cytokine that exhibits both anti-inflammatory activity and 
control of cell proliferation and differentiation [57].  IL-10 is also induced in 
macrophages on the uptake of apoptotic neutrophils and contributes to the resolution 
of lung injury [58]. In the skin, IL-10 is needed for an appropriately controlled repair 
response as IL-10-deficient mice show a sustained inflammatory response, which 
subsequently leads to increased collagen deposition in scar tissue [59].  Overall, IL-10 
is increasingly recognised as central to quality tissue repair, at least in part through its 
ability to suppress inflammation [60]. 
 
Another strategy to dampen inflammation is the induction of interleukin-1 receptor 
antagonist (IL-1Ra) [61]. IL-1Ra is a member of the IL-1 family that binds to IL-1 
receptors but does not induce any intracellular response. IL-1Ra therefore is able to 
inhibit the effects of IL-1α and IL-1β [62, 63], which are pro-inflammatory cytokines 
released at a very early phase of wounding upon tissue disruption [64]. In particular 
the sustained and sometimes excessive influx and activation of neutrophils into the 
wound is detrimental for the wound healing process [1]. Macrophage-derived IL-1ra 
dampens the local release of the chemokine MIP-2 and the local expression of the 
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epithelial adhesion molecule ICAM-1, in this way attenuating neutrophil recruitment. 
Since IL-1β is a critical survival signal for neutrophils, the local blockade of IL-1β by 
macrophage-derived IL-1ra within the wound may also induce apoptosis in wound-
resident neutrophils [56, 61]. In addition has it been shown that by expressing the 
apoptosis-inducing ligand TRAIL, macrophages can directly induce apoptosis in 
neutrophils [65].  
 
The intricate connection between repair and resolution of inflammation is 
demonstrated by a number of macrophage-derived cytokines that show a dual 
functionality. Best known is TGF, which directly contributes to the process of 
wound healing, while at the same time suppressing local inflammation. Another good 
example is the Epidermal Growth Factor (EGF)-like growth factor Amphiregulin 
[66]. Amphiregulin can induce the differentiation of tissue precursor cells within 
wounds [67]. At the same time, Amphiregulin can enhance local regulatory T cell 
function [68, 69] thereby suppressing local inflammation. When Amphiregulin is 
produced by activated alveolar macrophages, it can protect against LPS-induced acute 
lung injury [70] and mice with a regulatory T cell specific deficiency of the EGF-R 
(FoxP3cre x EGF-R
fl/fl
), which cannot respond to Amphiregulin, show a marked delay 
in skin wound repair [71].  Further, intra-nasal administration of Amphiregulin 
protects mice from lethal lung infections by promoting tissue integrity and repair [72, 
73]. Although Tregs themselves are important source of Amphiregulin during wound 
healing [74], the exact cellular sources need further study.  
 
Macrophage-derived arginase is another excellent example of a molecule that 
demonstrates the close relationship of tissue repair activities to suppression of 
inflammation.  Arginase converts arginine into ornithine, which can serve as a 
precursor for the synthesis or proline and hydroxyproline, which are central 
constituents of collagen. Additionally, ornithine feeds into the biosynthetic pathway 
for polyamines, which are required for cellular proliferation [75]. The activity of 
arginase also suppresses the inflammatory response because arginase competes with 
iNOS for their common substrate, arginine. Additionally by reducing the extra-
cellular arginine concentration, arginase suppresses activated T cells, which are 
highly arginine-dependent [76]. 
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IL-4 receptor signaling to macrophages during tissue repair 
Arginase is considered a marker for macrophages activated via the IL-4receptor 
(M(IL-4)) [77] and thus M(IL-4) or ‘alternatively activated’ macrophages have long 
been considered to have tissue repair function [78]. However, arginase can be induced 
by many different factors including IL-10, and thus the specific importance of M(IL-
4) to tissue repair has been a matter of some debate.  Recent studies have ended this 
debate by providing direct evidence for the contribution of M(IL-4) to tissue repair 
along with detailed mechanistic insight.  In mice lacking the IL-4Rα on macrophages, 
skin wound healing was delayed and vascular stability impaired [79]. Knipper et al. 
further showed that the IL-4Rα-inducible protein RELMα when produced by 
macrophages instructed fibroblasts to produce lysyl hydroxylase 2 (LH2) [79]. LH2 is 
an enzyme that directs collagen cross-links that are biochemically more stable and 
less likely to be degraded by enzymes than those found in uninjured skin. These 
findings demonstrate that although fibroblasts are the main matrix producing cells, 
macrophages critically regulate the synthesis and organization of de-novo collagen 
depositions in the wound. 
 
Assessing the contribution of M(IL-4) in the lung during wound healing has been 
somewhat complicated by the fact that alveolar macrophages already express markers 
typically associated with M(IL-4), such as Ym1 and CD206, and rapidly secrete 
typical M(IL-4) growth factors, such as Amphiregulin [80-82]. While alveolar 
macrophages in the steady state exhibit STAT-6 activation and arginase expression 
(C. Minutti, unpublished data), they have little or no basal iNOS expression and 
STAT1 phosphorylation [83], typical markers of classical activation of macrophages 
derived from other tissues. Therefore alveolar macrophages are considered to be 
somewhat biased even at steady-state.  Indeed, the anti-inflammatory properties of 
alveolar macrophages, as well as M(IL-4) macrophages may contribute to the ability 
of the lung to avoid over-reaction to innocuous substances.  Consistent with this 
concept, depletion of CD206+ macrophages substantially exaggerated lung injury in 
endotoxemic mice [84].   
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More direct evidence for the contribution of M(IL-4) in promoting lung repair came 
from studies of the lung migrating nematode, Nippostrongylus brasiliensis, which 
leads to the expansion of large numbers of highly activated M(IL-4) [85]. Depletion 
of macrophages exacerbated the hemorrhaging caused by worm migration and led to 
more severe acute lung injury.  Macrophage depletion also resulted in a significant 
reduction in insulin-like growth factor 1 (IGF-1) and arginase, both of which are 
induced by IL-4 and are important for repair in this lung injury model [85]. IGF-1 
stimulates the proliferation and survival of fibroblasts and myofibroblasts to promote 
matrix production and wound closure [86]. In addition to IGF-1 and arginase many 
other repair proteins are regulated by IL-4 or IL-13 in macrophages [87]. Taken 
together, the studies on M(IL-4) suggest that in both tissues, the skin as well as the 
lung, their involvement is likely to be most prominent during the tissue formation 
stage as they appear to contribute to cellular proliferation, regulation of fibroblasts, 
collagen production and cross-linking while exerting broadly anti-inflammatory 
functions.  
 
Contribution of macrophages to tissue re-organisation 
The final stage of wound healing is the “tissue-remodeling” phase, during which a 
process of wound re-organization restructures the tissue back to its original form 
(Figure 1). The re-organization of wounded tissue is a multi-step process and during 
this phase, which can last for weeks or even months, tissue resident endothelial cells, 
macrophages and myo-fibroblasts undergo apoptosis, newly formed blood vessels 
regress and remodeling and re-organization of the newly formed collagen layer 
underneath the wound occurs (Figure 1). During this phase of wound healing, 
macrophages contribute to wound healing by ingesting cell debris and contributing to 
the degradation of excess ECM that had built up in and around the wound [88]. 
Nevertheless, depletion of skin macrophage in the tissue-remodeling phase does not 
have a substantial impact on the outcome of wound healing, suggesting that 
macrophages are part of a redundant system of tissue re-organisation and at this stage 
of wound repair their functions could be taken over by other wound resident cell 
populations [7]. 
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Macrophages have been suggested to have a major role in the breakdown of matrix 
fragments by phagocytic uptake and intracellular degradation [89]. However, matrix 
fragments are also degraded enzymatically by secreted metalloproteinases, cysteine 
proteinases (cathepsin B and L) or serine proteases (eg plasmin). In particular, matrix 
metalloproteinases (MMPs) represent a group of enzymes involved in the degradation 
of most of the components of the collagen layer underneath wounds [90]. MMPs can 
be produced by macrophages (Figure 3a), but can also be produced by other cells at 
the wound site such as neutrophils, keratinocytes or fibroblasts.  A specific function 
of macrophage-derived MMPs was recently identified for MMP-10 [91]. MMP-10 
knock out mice produce a stiffer and more collagenous scar tissue compared to wild 
type mice indicating that MMP-10 is critical for collagen breakdown in skin wound 
healing. Macrophage depletion and adoptive transfer experiments demonstrated that 
macrophage-derived MMP-10 was critical for the collagenolytic activity in part by 
regulating the production of other MMPs by macrophages, particularly MMP13 [91]. 
 
Alveolar macrophages have been shown to produce MMP1, MMP2, MMP7 and 
MMP12 [92-94] (Figure 3a). In addition, it has been shown that macrophage-derived 
12-lipoxygenase metabolites induce MMPs by lung fibroblasts during lung 
inflammation [95]. Furthermore, it has been observed that alveolar macrophages 
contain evident collagen by-products in animal models of emphysema, suggesting that 
alveolar macrophages can contribute to collagen catabolism [96]. Overall, the specific 
contribution of macrophages to this final repair stage requires further investigation, in 
particular whether macrophages are absolutely required, and if so, what cytokines or 
factors drive their reparative phenotype.   
 
Conclusion and Outlook  
The comparison of the role of macrophages in the process of wound healing in two 
distinct tissues has highlighted key similarities that likely reflect evolutionarily 
conserved pathways in tissue repair. In both the lung and the skin, the process of 
wound healing transitions through similar phases with macrophages performing 
similar functions (Figure 1). Tissue-resident macrophages in either tissue are an 
essential sentinel, which recognizes tissue damage and substantially contributes to the 
initiation of a local pro-inflammatory environment. The pro-inflammatory 
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environment then allows the influx of monocyte populations into the wound of both 
tissues, where they then differentiate in a tissue-specific manner and perform essential 
tissue repair functions that tissue-resident macrophage populations could not perform 
on their own. The reliance of both tissues on macrophage-derived growth factors for 
cell proliferation and differentiation within the wound, is also a shared characteristic, 
although lung resident macrophages are from the start more polarized towards a 
wound healing and inflammation-resolving phenotype. In both tissues, macrophages 
then actively contribute to the resolution of local inflammation and to the re-
organization of the wounded tissue. 
 
There is a fundamental limitation to the comparison of macrophage function between 
different tissues, and that is the very different nature of the experiments that are 
performed. Skin wound healing is often based on well-defined incisional or excisional 
wounds. In contrast, wounding in experimental lung models is often introduced either 
by a general physical disruption of lung structure, for instance, via forced ventilation 
or exposure to a strong cell irritant, such as bleomycin, or by the transition of the 
nematode Nippostrongylus brasiliensis through the lung tissue. Another current 
limitation is the fact that key experiments, such as tracking of different monocyte 
populations into the healing wound, have exclusively been performed in one model 
system but not in the other.  Nevertheless, a number of differences in macrophage 
function in the two tissues have become apparent. For example, while wounds in both 
tissues go through very similar phases of wound repair, the dynamics of these 
different phases are different (Figure 3b). Puncture induced wounding in the skin can 
require weeks to complete the process of wound healing. In contrast, lungs punctured 
by migrating worm larvae, fully recover within days [85, 97, 98]. While the different 
phases of wound repair within the skin are clearly distinguishable and follow a clear 
chronological order, these phases in the lungs overlap considerably. There is a strong 
indication that the “tissue formation” phase with its macrophage mediated secretion of 
growth factor is already initiated in the lung before the “coagulation phase” has been 
completed [99] (Figure 3b). This rapid initiation of wound repair may be a 
consequence of the fact that alveolar macrophages are already skewed towards wound 
repair. The unique environment of the lung as a highly exposed organ significantly 
contributes to the phenotype of alveolar macrophages by providing local factors that 
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increase their activation threshold and thereby imprints the characteristic tolerogenic 
response in the lung. This characteristic of the lung may also explain another 
difference between the two tissues, which is the distinct regenerative capacity of these 
different tissues to re-organize wounded tissue back into its original structure. Wound 
repair in skin tissue is focused on restoration of skin integrity, however, many aspects 
of original skin structure with their highly differentiated compartmentalization is not 
re-created. In contrast, lung tissue, even after severe damaging or the surgical removal 
of parts of lung lobes, has a remarkable regenerative capacity that can lead to 
restoration of alveolar architecture [51, 100].  
 
Our review of the literature also revealed a number of unanswered questions. One of 
the most pressing of these questions is the exact role that different monocyte 
populations and monocytes-derived macrophage populations play during wound 
healing and how they function in comparison to tissue resident macrophages (Figure 
3a). CCR-2 and CX3CR-1 expressing monocytes in skin models have distinct 
functions but also immigrate to the wound at different stages of wound repair and 
therefore encounter fundamentally distinct local inflammatory conditions (Figure 3a). 
While CCR-2 expressing monocytes immigrate during a pro-inflammatory 
environment CX3CR-1 expressing monocytes enter at a stage when the pro-
inflammatory environment has started to resolve and when wound-resident 
macrophage populations become polarized towards a more alternatively activated 
phenotype. CCR-2 expressing monocytes recruited to allergic skin can also acquire an 
alternative polarized phenotype, highlighting monocyte plasticity and context-
dependence of monocyte differentiation and macrophage polarization [101]. In the 
lung, with its more polarizing environment recruited monocytes rapidly differentiate 
into fully functional alveolar macrophages [102, 103]. However, regardless of the 
dynamics of differentiation, for both locations, in the skin as in the lung, it became 
apparent that monocyte-derived macrophages in both tissues have specific functions 
during tissue repair, which separate them from tissue-resident macrophages.  
 
In conclusion, we have aimed to describe the contribution of macrophages to 
processes involved in appropriate tissue repair under normal physiological conditions. 
However, it is critical to note that failure at any of the steps discussed above can result 
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in a pathological outcome (Figure 3b). Thus inflammation must be initiated for 
efficient healing [104], but if it is not resolved the consequence can be non-healing 
ulcers, or a constant battle between inflammation and matrix deposition leading to 
severe fibrosis [82, 105].  Similarly, collagen deposition must stop or otherwise scar 
tissue and loss of tissue function will ensue, and finally the breakdown and rebuilding 
of matrix that characterizes the final stages must be appropriated controlled or the 
continual remodeling of tissue will compromise it’s functional integrity.  Because of 
their central role in the orchestration of efficient and high quality tissue repair, 
macrophages are also central to the processes that fail. Thus by fully understanding 
the contribution of tissue-specific as well as common functions of macrophages that 
ensure proper repair, macrophages will be increasingly attractive targets for therapy 
against diseases that result from poor quality repair.     
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Figure 1: Sequent phases of physiological skin wound healing.  
During the “Coagulation and Inflammation” phase, immediately after injury, tissue-resident 
macrophages contribute to the initiation of a local inflammatory response, which leads to the influx 
of high numbers of neutrophils into the wound. In parallel, a fibrin clot forms, around which a 
provisional protective matrix is formed.  During the “Tissue Formation” phase, a highly 
vascularized granulation tissue develops within the wound, comprising of a high cell density of 
mainly macrophages, fibroblasts and endothelial cells. Keratinocytes migrate from the wound 
margins to close the epidermal gap.  During the “Tissue Reorganisation” phase, macrophages 
contribute to the active remodelling of the extra-cellular matrix within the wound, leaving behind a 
scar tissue that is characterized by increased matrix deposition and reduced cellular density. 
Figure 2: Architecture of skin vs. alveoli.  
The skin is composed of two layers: the epidermis and the dermis. The epidermis provides a 
physical, chemical and immunological barrier from the outside environment. The epidermis is a 
squamous epithelium composed of different layers, supported by self-renewing proliferating tissue-
stem cells. In contrast, the dermis is a structure rich in extracellular matrix that provides tensile 
strength and elasticity. The dermis is tightly connected to the epidermis by the basement membrane 
and consists of different cell types, including fibroblasts and endothelial cells. Appendages such as 
hair roots, sebaceous glands and sweat glands are located in the dermal part.  Langerhans cells are 
located in the epidermal layer whereas dermal macrophages are the dominant macrophage 
population in the dermal layer. 
The pulmonary alveoli are the terminal ends of the respiratory tree forming an anatomical 
structure that allows for oxygen uptake. The alveolar sacs are composed of a thin alveolar 
epithelium composed of two cell types: thin, squamous type I cells, which cover 95% of the 
alveolar surface and form the structure of the alveolar wall, and cuboidal type II cells that secrete 
pulmonary surfactant. Surrounding the alveolar sacs, the lung interstitium is a connective tissue-rich 
framework for the alveoli and contains the interstitial macrophages. Lining the airway lumen 
alveolar macrophages are embedded in the alveolar fluid rich in pulmonary surfactants providing a 
barrier for lung defence.  
 
Figure legends
Figure 3:  
In all three phases of wound repair (Coagulation and Inflammation, Tissue Formation and Tissue 
Reorganisation) resident macrophages and monocyte-derived macrophage populations play 
essential but distinct functions. a) Following injury, tissue-resident macrophage populations 
function as sentinels and become rapidly activated and contribute to a pro-inflammatory 
environment within the wound. During the “Coagulation and Inflammation” phase, this pro-
inflammatory environment induces the influx of the first wave of CCR-2 expressing monocytes into 
the wound, which is then followed by a second wave of CX3CR-1 expressing monocytes. These 
recruited monocyte populations undergo marked phenotypic and functional changes in response to 
IL-4 as well as to tissue-specific factors. During this phase, the pro-inflammatory environment is 
resolved and macrophage derived growth factors contribute to tissue repair and regeneration. This 
resolving environment initiates the “Tissue Reorganisation” during which macrophages contribute 
to the degradation of cell debris and the re-organisation of excessive ECM material and thus the 
restoration of affected tissue. b) This process of wound repair is conserved in both the lung as the 
skin but the dynamics of the distinctive phases differ between the tissues, with the lung tissue 
recovering faster than the skin. Disruption of this process leads to pathology, which manifests itself 
as fibrosis or emphysema in the lung and as extended scar tissue in the skin.  
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